Bipartisan concern in Congress about hospitals' compliance with new price transparency rules might enhearten drugmakers and others who want to impose reporting requirements on 340B hospitals. | Shutterstock

Could Concern About Hospital Price Transparency Boost Push for More Hospital 340B Transparency?

The bipartisan leaders of the U.S. House Energy and Commerce (E&C) Committee and its Health Subcommittee wrote to U.S. Health and Human Services (HHS) Secretary Xavier Becerra this week asking him to enforce “full compliance” with the Trump administration’s hospital price transparency rule.

“We are concerned about troubling reports of some hospitals either acting slowly to comply with the requirements of the final rule, or not taking any action to date to comply,” the Democratic and Republican committee leaders said. The E&C Committee has jurisdiction over the 340B and Medicaid programs.

Drugmakers and others who want more reporting requirements for 340B hospitals might take heart from bipartisan concern in Congress about hospitals evading new price transparency rules. | Shutterstock

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


*Sign up for news summaries and alerts from 340B Report

Site Footer